← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Jillion Therapeutics Inc.
New York, NY
$1,693,833
Total funding
4
Grants
Funding over time
peak $896.3K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,693,833 · 4
By mechanism
R43$1,693,833 · 4
Investigators at Jillion Therapeutics Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Targeting biologically relevant tau monomers and oligomers using a novel DEL drug discovery platform to treat Alzheimerâs disease and tauopathies$496,373
R43 · FY2024 · AG
The use of DNA-encoded library (DEL) technology for the identification of therapeutic molecules to treat opioid use disorders (OUDs)$399,884
R43 · FY2024 · DA
Synergy between Artificial Intelligence and DNA-Encoded Library technologies to Identify Polypharmacological Therapeutics for Substance Use Disorders$399,483
R43 · FY2025 · DA
Identification of therapeutic molecules to treat amphetamine use disorders using our DNA-encoded library (DEL) technology$398,093
R43 · FY2025 · DA